Page last updated: 2024-11-03

propranolol and Geographic Atrophy

propranolol has been researched along with Geographic Atrophy in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Geographic Atrophy: A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, A1
Cohen, SM1
Pautler, SE1
Billiris-Findlay, K1
Eichenbaum, DA1

Other Studies

1 other study available for propranolol and Geographic Atrophy

ArticleYear
Beta blocker use and age-related macular degeneration.
    Acta ophthalmologica, 2012, Volume: 90, Issue:2

    Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Aged, 80 and over; Drug

2012